Goldman Sachs’s eFFECTOR Therapeutics, Inc. Warrant EFTRW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-630,539
| Closed | -$757 | – | 5096 |
|
|
2024
Q2 | $757 | Hold |
630,539
| – | – | ﹤0.01% | 4711 |
|
|
2024
Q1 | $85.2K | Hold |
630,539
| – | – | ﹤0.01% | 4480 |
|
|
2023
Q4 | $45.5K | Hold |
630,539
| – | – | ﹤0.01% | 4552 |
|
|
2023
Q3 | $47.9K | Hold |
630,539
| – | – | ﹤0.01% | 4487 |
|
|
2023
Q2 | $86.4K | Hold |
630,539
| – | – | ﹤0.01% | 4590 |
|
|
2023
Q1 | $47.3K | Hold |
630,539
| – | – | ﹤0.01% | 4778 |
|
|
2022
Q4 | $48.9K | Hold |
630,539
| – | – | ﹤0.01% | 4792 |
|
|
2022
Q3 | $128K | Buy |
630,539
+125,000
| +25% | +$25.4K | ﹤0.01% | 4855 |
|
|
2022
Q2 | $101K | Hold |
505,539
| – | – | ﹤0.01% | 5120 |
|
|
2022
Q1 | $175K | Hold |
505,539
| – | – | ﹤0.01% | 5143 |
|
|
2021
Q4 | $445K | Sell |
505,539
-2,245
| -0.4% | -$1.98K | ﹤0.01% | 4590 |
|
|
2021
Q3 | $812K | Buy |
+507,784
| New | +$812K | ﹤0.01% | 4116 |
|